← Leaderboards
Simeon Kolawole Adesina
Howard University
$888,375
Attributed
$888,375
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $347.6K · FY2019–21$500K$375K$250K$125K$0
'19
'20
'21
Funding mix
By agency
NIH$888,375 · 1
By mechanism
SC1$888,375 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Adverse Effects”
- Susan Abushakra · Alzheon, Inc.$47,265,244
- Kristin Aillon · Midwest Research Institute$23,644,534
- Abraham Aizer Brody · New York University School Of Medicine$21,887,280
- Ellen Gould Chadwick · Harvard University D/B/A Harvard School Of Public Health$21,828,548
- Ionut Bebu · George Washington University$18,816,779
- Barbara Halina Braffett · George Washington University$18,816,779
Research focus
Adverse EffectsAmidesAmino GroupAffectAntioxidantsAqueousBaseBindingBiodistributionAnimalsCancer CellCancer ModelCancer SiteCarbonCarboxylic AcidsCastration Resistant Prostate CancerCell Culture TechniquesCell DeathCell LineCellsCell SurvivalBruceaChemotherapeutic AgentChemotherapy
Grant awards (3)
Stealth Brusatol and Docetaxel-loaded Nanoparticles for Targeted Prostate Cancer Therapy$347,625
SC1 · FY2021 · GM · contact PI
Stealth Brusatol and Docetaxel-loaded Nanoparticles for Targeted Prostate Cancer Therapy$231,750
SC1 · FY2020 · GM · contact PI
Stealth Brusatol and Docetaxel-loaded Nanoparticles for Targeted Prostate Cancer Therapy$309,000
SC1 · FY2019 · GM · contact PI